4
H index
2
i10 index
141
Citations
Jeffrey Hoch : Citation Profile
University of California-Davis | RESEARCH PRODUCTION: 20 Articles 4 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
22 years (2002 - 2024). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Jeffrey Hoch. | Is cited by:
| Cites to:
|
Main data
Where Jeffrey Hoch has published?
| Journals with more than one article published | # docs |
|---|---|
| PharmacoEconomics | 7 |
| PharmacoEconomics - Open | 4 |
| PLOS ONE | 2 |
| Health Economics | 2 |
| Medical Decision Making | 2 |
Recent works citing Jeffrey Hoch (2025 and 2024)
| Year | Title of citing document |
|---|---|
| 2024 | Cost-effectiveness of a parenting program to reduce children’s behavioral problems among families receiving child protection services and other family support services – A randomized controlled trial. (2024). Sääksvuori, Lauri ; Karjalainen, Piia ; Kiviruusu, Olli ; Linnosmaa, Ismo ; Rissanen, Elisa ; Kankaanpaa, Eila ; Aronen, Eeva T ; Haula, Taru ; Vornanen, Riitta. In: Children and Youth Services Review. RePEc:eee:cysrev:v:158:y:2024:i:c:s019074092400063x. Full description at Econpapers || Download paper |
| 2024 | Public preferences for the allocation of societal resources over different healthcare purposes. (2024). van Exel, Job ; Boxebeld, Sander ; Mouter, Niek ; van Agthoven, Michel ; Maes, Laurence ; Tuit, Charlotte ; Makady, Amr ; Geijsen, Tom. In: Social Science & Medicine. RePEc:eee:socmed:v:341:y:2024:i:c:s0277953623008936. Full description at Econpapers || Download paper |
| 2024 | ‘Managing values’ in health economics modelling: Philosophical and practical considerations. (2024). Winsberg, Eric B ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:358:y:2024:i:c:s027795362400710x. Full description at Econpapers || Download paper |
| 2025 | Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework. (2025). Pataky, Reka E ; Peacock, Stuart ; Bryan, Stirling ; Sadatsafavi, Mohsen ; Regier, Dean A. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:3:d:10.1007_s40258-024-00926-9. Full description at Econpapers || Download paper |
| 2024 | Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma. (2024). Schlueter, Max ; Laramee, Philippe ; Meyer, Nicolas ; Macabeo, Brengre ; Nikolaidis, Georgios F ; Trouiller, Jean-Baptiste ; Gerlier, Laetitia. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01614-6. Full description at Econpapers || Download paper |
| 2024 | Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people. (2024). Steele, Mary ; Clarke, Holly ; Onoja, Mary ; Griffiths, Gareth ; Sach, Tracey H ; Yardley, Lucy ; Stuart, Beth ; Becque, Taeko ; Howells, Laura ; Ahmed, Amina ; Wilczynska, Sylvia ; Thomas, Kim S ; Roberts, Amanda ; Langan, Sinead M ; Sivyer, Katy ; Lawton, Sandra ; Greenwell, Kate ; Little, Paul ; Hooper, Julie ; Leighton, Paul ; Nuttall, Jacqui ; Santer, Miriam ; Muller, Ingrid ; Ridd, Matthew J ; Williams, Hywel C. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:7:d:10.1007_s10198-023-01649-9. Full description at Econpapers || Download paper |
| 2025 | A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care. (2025). Neslusan, Cheryl A ; Willis, Michael S ; Nilsson, Andreas. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:6:d:10.1007_s40273-025-01478-z. Full description at Econpapers || Download paper |
Works by Jeffrey Hoch:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2008 | Measuring and illustrating statistical evidence in a cost-effectiveness analysis In: Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2014 | Public engagement in priority-setting: Results from a pan-Canadian survey of decision-makers in cancer control In: Social Science & Medicine. [Full Text][Citation analysis] | article | 2 |
| 2021 | Labs and cases in health insurance and cost-effectiveness analyses to enhance active learning experiences in an introductory healtheconomics course for students in health professions In: Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 2021 | Using net benefit regression to teach cost-effectiveness analysis with a dataset In: Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 2018 | Econometric Considerations When Using the Net Benefit Regression Framework to Conduct Cost-effectiveness Analysis In: Contributions to Economic Analysis. [Full Text][Citation analysis] | chapter | 0 |
| 2016 | Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors In: PLOS ONE. [Full Text][Citation analysis] | article | 1 |
| 2017 | Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening In: PLOS ONE. [Full Text][Citation analysis] | article | 1 |
| 2014 | A Review and Meta-analysis of Colorectal Cancer Utilities In: Medical Decision Making. [Full Text][Citation analysis] | article | 4 |
| 2024 | A Tutorial on Net Benefit Regression for Real-World Cost-Effectiveness Analysis Using Censored Data from Randomized or Observational Studies In: Medical Decision Making. [Full Text][Citation analysis] | article | 0 |
| 2016 | Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2013 | Improving the Efficiency of Cost-effectiveness Analysis to Inform Policy Decisions in the Real World: Lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario In: International Series in Operations Research & Management Science. [Citation analysis] | chapter | 0 |
| 2007 | Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
| 2013 | The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
| 2015 | Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2015 | Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale? In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2018 | Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2019 | A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2024 | Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2017 | Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2017 | Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR) In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2018 | The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2018 | Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2002 | Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis In: Health Economics. [Full Text][Citation analysis] | article | 74 |
| 2004 | Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data In: Health Economics. [Full Text][Citation analysis] | article | 47 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated December, 22 2025. Contact: CitEc Team